Table 1.
Changes due to tDCS in CBF, Yv and CMRO2.
Parameter | PRE-tDCS (mean ± SD) | DUR-tDCS (mean ± SD) | POST-tDCS (mean ± SD) | p-value (paired t-test) |
||
---|---|---|---|---|---|---|
PRE vs DUR | DUR vs POST | PRE vs POST | ||||
Global CBF (mL/100g/min) | 53.67 ± 7.75 | 57.10 ± 8.33 | 56.79 ± 8.70 | <0.0001**** | 0.7475 | 0.0009*** |
Yv (%) | 60.71 ± 4.12 | 60.96 ± 4.37 | 60.39 ± 4.66 | 0.6698 | 0.4887 | 0.7167 |
CMRO2 (μ mol/100g/min) | 165.84 ± 25.32 | 175.68 ± 30.78 | 176.86 ± 28.58 | 0.0015** | 0.7971 | 0.0150* |
Notes: Comprehensive table of measurements for global cerebral blood flow (CBF), venous blood oxygenation (Yv) and calculated cerebral metabolic rate of oxygen (CMRO2). Interestingly, the elevated levels of CBF and CMRO2 due to tDCS persist even after the stimulation (post-tDCS).